illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. PacBio
Company logo

PacBio | Sustainability Performance

https://www.pacb.com
Linkedin

Develops and manufactures genetic sequencing systems, offering technology for biological research and genomic analysis applications.

2004

United States

501 - 1,000 employees

Biotechnology

$100M - 500M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#5730
Overall
#1209
in United States
#109
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

81 out of 251

Overview
Environmental
Digital emissions
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Arcturus Therapeutics

United States, Hospital & Health Care, Biotechnology

Company logo
NeueHealth

United States, Hospital & Health Care, Hospital & Health Care

Company logo
Envista

United States, Hospital & Health Care, Medical Device

Market cap

409.0M $, 2026▲6.1% YoY

Revenue

160.0M $, 2025▲3.8% YoY

R&D intensity

60.62% 2025

Digital Emissions

CO2e per visit (g)

Industry benchmark

B/M 0.26 g
1.37 g
D
Environmental ScoreScore D
Green HostingYes
Download Digital Emissions AnalysisPowered by illuminem and Dedalo AI

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • PacBio's sequencing uses specialty reagent chemicals.
Powered by illuminem

Market cap

409.0M $, 2026▲6.1% YoY

Revenue

160.0M $, FY2025▲3.8% YoY

EBITDA

-552.0M $, FY2025▼9.1% YoY

Operating margin

-348% Industry: -370▲11.6% YoY

Revenue & EBITDA

$160.0MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Revenue by region

Revenue by region %

Asia Pacific [Member]
Europe [Member]
North America [Member]

Powered by illuminem

Margin trends

Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-118.9M 2025▼78.5% YoY

Capex

7.0M 2025▲14.3% YoY

Debt/equity ratio

120.7 Industry: 2▼NaN% YoY

R&D intensity

60.6%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-84.0%FY2026
Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals

Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.2

▲ 0.3%

2023

0.2

▼ 0.9%

2024

0.2

▲ 1.0%

2025

0.3

2030

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

67%
Independent Directors

8 out of 12 incl. management

Powered by illuminem

Overall score

42

Environment

16

Social

60

Governance

51

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available

Sustainability employees

Total sustainability employees

2-3

    Available in
    Scale package

    Access
  • Email
  • Email